Literature DB >> 21956205

Genome-wide identification of TCF7L2/TCF4 target miRNAs reveals a role for miR-21 in Wnt-driven epithelial cancer.

Fengming Lan1, Xiao Yue, Lei Han, Zhendong Shi, Yang Yang, Peiyu Pu, Zhi Yao, Chunsheng Kang.   

Abstract

Transcription factor 7 like 2 (TCF7L2, also known as TCF4) is a Wnt signaling pathway transcription factor involved in regulation of numerous Wnt targeted genes. Recently, thousands of high-confidence TCF4 binding sites were reported in LS174T colon carcinoma cells, however, potential TCF4 target miRNAs remain largely unknown. Here, we utilized a bioinformatics approach to discover 26 miRNA transcription start sites (TSSs) within close proximity to TCF4 chromatin occupancy sites, and validated these sites as bona fide TCF4 targets in LS174T colon carcinoma cells, MCF-7 breast cancer cells and U87 glioma cells by ChIP-PCR. We then selected miR-21 to demonstrate for the first time direct TCF4 transcriptional activation of a miRNA via binding to the promoter region. Tissue array analysis supported this finding, revealing a positive correlation between activation of the β-catenin pathway and in situ expression of miR-21. Finally, based upon the well known but poorly understood preventive effect of aspirin on colorectal cancer incidence and mortality, we report downregulation of miR-21 upon administration of aspirin. In sum, our findings identify direct transcriptional regulation of miR-21 by TCF4 and suggest a role for miR-21 in cancer cell proliferation and invasion upon activation of β-catenin/TCF4 signaling.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21956205     DOI: 10.3892/ijo.2011.1215

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  24 in total

Review 1.  Wnt/beta-catenin signaling in glioma.

Authors:  Kailiang Zhang; Junxia Zhang; Lei Han; Peiyu Pu; Chunsheng Kang
Journal:  J Neuroimmune Pharmacol       Date:  2012-03-28       Impact factor: 4.147

2.  miR-137 suppresses proliferation, migration and invasion of colon cancer cell lines by targeting TCF4.

Authors:  Wei-Ping Bi; Min Xia; Xin-Jian Wang
Journal:  Oncol Lett       Date:  2018-03-28       Impact factor: 2.967

Review 3.  Aspirin sensitivity of PIK3CA-mutated Colorectal Cancer: potential mechanisms revisited.

Authors:  Daniella C N Hall; Ralf A Benndorf
Journal:  Cell Mol Life Sci       Date:  2022-07-02       Impact factor: 9.207

4.  Reversion-inducing cysteine-rich protein with Kazal motifs and its regulation by glycogen synthase kinase 3 signaling in oral cancer.

Authors:  Kamdeo K Pramanik; Abhay K Singh; Manzar Alam; Tanushree Kashyap; Prajna Mishra; Aditya K Panda; Ratan K Dey; Ajay Rana; Siddavaram Nagini; Rajakishore Mishra
Journal:  Tumour Biol       Date:  2016-09-30

Review 5.  Targeting epigenetic mechanisms and microRNAs by aspirin and other non steroidal anti-inflammatory agents--implications for cancer treatment and chemoprevention.

Authors:  Eugenia Yiannakopoulou
Journal:  Cell Oncol (Dordr)       Date:  2014-07-05       Impact factor: 6.730

Review 6.  Opposite Interplay Between the Canonical WNT/β-Catenin Pathway and PPAR Gamma: A Potential Therapeutic Target in Gliomas.

Authors:  Alexandre Vallée; Yves Lecarpentier; Rémy Guillevin; Jean-Noël Vallée
Journal:  Neurosci Bull       Date:  2018-03-26       Impact factor: 5.203

Review 7.  MicroRNAs as growth regulators, their function and biomarker status in colorectal cancer.

Authors:  Lina Cekaite; Peter W Eide; Guro E Lind; Rolf I Skotheim; Ragnhild A Lothe
Journal:  Oncotarget       Date:  2016-02-09

8.  Next-generation sequencing reveals novel differentially regulated mRNAs, lncRNAs, miRNAs, sdRNAs and a piRNA in pancreatic cancer.

Authors:  Sören Müller; Susanne Raulefs; Philipp Bruns; Fabian Afonso-Grunz; Anne Plötner; Rolf Thermann; Carsten Jäger; Anna Melissa Schlitter; Bo Kong; Ivonne Regel; W Kurt Roth; Björn Rotter; Klaus Hoffmeier; Günter Kahl; Ina Koch; Fabian J Theis; Jörg Kleeff; Peter Winter; Christoph W Michalski
Journal:  Mol Cancer       Date:  2015-04-25       Impact factor: 27.401

Review 9.  MicroRNA and HER2-overexpressing cancer.

Authors:  Shizhen Emily Wang; Ren-Jang Lin
Journal:  Microrna       Date:  2013

10.  Wnt/β-catenin pathway transactivates microRNA-150 that promotes EMT of colorectal cancer cells by suppressing CREB signaling.

Authors:  Yan-Hua Guo; Lu-Qin Wang; Bin Li; Hui Xu; Jian-Hua Yang; Li-Si Zheng; Peng Yu; Ai-Dong Zhou; Yin Zhang; Shu-Juan Xie; Zi-Rui Liang; Chen-Min Zhang; Hui Zhou; Liang-Hu Qu
Journal:  Oncotarget       Date:  2016-07-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.